IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v15y2024i1d10.1038_s41467-024-51848-y.html
   My bibliography  Save this article

Administration of anti-HIV-1 broadly neutralizing monoclonal antibodies with increased affinity to Fcγ receptors during acute SHIVAD8-EO infection

Author

Listed:
  • Joana Dias

    (National Institutes of Health)

  • Giulia Fabozzi

    (National Institutes of Health)

  • Slim Fourati

    (Emory University)

  • Xuejun Chen

    (National Institutes of Health)

  • Cuiping Liu

    (National Institutes of Health)

  • David R. Ambrozak

    (National Institutes of Health)

  • Amy Ransier

    (National Institutes of Health)

  • Farida Laboune

    (National Institutes of Health)

  • Jianfei Hu

    (National Institutes of Health)

  • Wei Shi

    (National Institutes of Health)

  • Kylie March

    (National Institutes of Health)

  • Anna A. Maximova

    (National Institutes of Health)

  • Stephen D. Schmidt

    (National Institutes of Health)

  • Jakob Samsel

    (National Institutes of Health
    George Washington University)

  • Chloe A. Talana

    (National Institutes of Health)

  • Keenan Ernste

    (National Institutes of Health)

  • Sung Hee Ko

    (National Institutes of Health)

  • Margaret E. Lucas

    (National Institutes of Health)

  • Pierce E. Radecki

    (National Institutes of Health)

  • Kristin L. Boswell

    (National Institutes of Health)

  • Yoshiaki Nishimura

    (National Institutes of Health)

  • John-Paul Todd

    (National Institutes of Health)

  • Malcolm A. Martin

    (National Institutes of Health)

  • Constantinos Petrovas

    (National Institutes of Health)

  • Eli A. Boritz

    (National Institutes of Health)

  • Nicole A. Doria-Rose

    (National Institutes of Health)

  • Daniel C. Douek

    (National Institutes of Health)

  • Rafick-Pierre Sékaly

    (Emory University)

  • Jeffrey D. Lifson

    (Frederick National Laboratory for Cancer Research)

  • Mangaiarkarasi Asokan

    (National Institutes of Health)

  • Lucio Gama

    (National Institutes of Health)

  • John R. Mascola

    (ModeX Therapeutics)

  • Amarendra Pegu

    (National Institutes of Health)

  • Richard A. Koup

    (National Institutes of Health)

Abstract

Anti-HIV-1 broadly neutralizing antibodies (bNAbs) have the dual potential of mediating virus neutralization and antiviral effector functions through their Fab and Fc domains, respectively. So far, bNAbs with enhanced Fc effector functions in vitro have only been tested in NHPs during chronic simian-HIV (SHIV) infection. Here, we investigate the effects of administering in acute SHIVAD8-EO infection either wild-type (WT) bNAbs or bNAbs carrying the S239D/I332E/A330L (DEL) mutation, which increases binding to FcγRs. Emergence of virus in plasma and lymph nodes (LNs) was delayed by bNAb treatment and occurred earlier in monkeys given DEL bNAbs than in those given WT bNAbs, consistent with faster clearance of DEL bNAbs from plasma. DEL bNAb-treated monkeys had higher levels of circulating virus-specific IFNγ single-producing CD8+ CD69+ T cells than the other groups. In LNs, WT bNAbs were evenly distributed between follicular and extrafollicular areas, but DEL bNAbs predominated in the latter. At week 8 post-challenge, LN monocytes and NK cells from DEL bNAb-treated monkeys upregulated proinflammatory signaling pathways and LN T cells downregulated TNF signaling via NF-κB. Overall, bNAbs with increased affinity to FcγRs shape innate and adaptive cellular immunity, which may be important to consider in future strategies of passive bNAb therapy.

Suggested Citation

  • Joana Dias & Giulia Fabozzi & Slim Fourati & Xuejun Chen & Cuiping Liu & David R. Ambrozak & Amy Ransier & Farida Laboune & Jianfei Hu & Wei Shi & Kylie March & Anna A. Maximova & Stephen D. Schmidt &, 2024. "Administration of anti-HIV-1 broadly neutralizing monoclonal antibodies with increased affinity to Fcγ receptors during acute SHIVAD8-EO infection," Nature Communications, Nature, vol. 15(1), pages 1-18, December.
  • Handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-51848-y
    DOI: 10.1038/s41467-024-51848-y
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-024-51848-y
    File Function: Abstract
    Download Restriction: no

    File URL: https://libkey.io/10.1038/s41467-024-51848-y?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Masashi Shingai & Yoshiaki Nishimura & Florian Klein & Hugo Mouquet & Olivia K. Donau & Ronald Plishka & Alicia Buckler-White & Michael Seaman & Michael Piatak & Jeffrey D. Lifson & Dimiter Dimitrov &, 2013. "Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia," Nature, Nature, vol. 503(7475), pages 277-280, November.
    2. Tae-Wook Chun & Richard T. Davey & Delphine Engel & H. Clifford Lane & Anthony S. Fauci, 1999. "Re-emergence of HIV after stopping therapy," Nature, Nature, vol. 401(6756), pages 874-875, October.
    3. Marina Caskey & Florian Klein & Julio C. C. Lorenzi & Michael S. Seaman & Anthony P. West & Noreen Buckley & Gisela Kremer & Lilian Nogueira & Malte Braunschweig & Johannes F. Scheid & Joshua A. Horwi, 2015. "Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117," Nature, Nature, vol. 522(7557), pages 487-491, June.
    4. Ann J. Hessell & Lars Hangartner & Meredith Hunter & Carin E. G. Havenith & Frank J. Beurskens & Joost M. Bakker & Caroline M. S. Lanigan & Gary Landucci & Donald N. Forthal & Paul W. H. I. Parren & P, 2007. "Fc receptor but not complement binding is important in antibody protection against HIV," Nature, Nature, vol. 449(7158), pages 101-104, September.
    5. Nicole A. Doria-Rose & Chaim A. Schramm & Jason Gorman & Penny L. Moore & Jinal N. Bhiman & Brandon J. DeKosky & Michael J. Ernandes & Ivelin S. Georgiev & Helen J. Kim & Marie Pancera & Ryan P. Staup, 2014. "Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies," Nature, Nature, vol. 509(7498), pages 55-62, May.
    6. Yoshiaki Nishimura & Rajeev Gautam & Tae-Wook Chun & Reza Sadjadpour & Kathryn E. Foulds & Masashi Shingai & Florian Klein & Anna Gazumyan & Jovana Golijanin & Mitzi Donaldson & Olivia K. Donau & Rona, 2017. "Early antibody therapy can induce long-lasting immunity to SHIV," Nature, Nature, vol. 543(7646), pages 559-563, March.
    7. Laura M. Walker & Michael Huber & Katie J. Doores & Emilia Falkowska & Robert Pejchal & Jean-Philippe Julien & Sheng-Kai Wang & Alejandra Ramos & Po-Ying Chan-Hui & Matthew Moyle & Jennifer L. Mitcham, 2011. "Broad neutralization coverage of HIV by multiple highly potent antibodies," Nature, Nature, vol. 477(7365), pages 466-470, September.
    8. Mariya B. Shapiro & Tracy Cheever & Delphine C. Malherbe & Shilpi Pandey & Jason Reed & Eun Sung Yang & Keyun Wang & Amarendra Pegu & Xuejun Chen & Don Siess & David Burke & Heidi Henderson & Rebecca , 2020. "Single-dose bNAb cocktail or abbreviated ART post-exposure regimens achieve tight SHIV control without adaptive immunity," Nature Communications, Nature, vol. 11(1), pages 1-13, December.
    9. Scott G. Hansen & Michael Piatak & Abigail B. Ventura & Colette M. Hughes & Roxanne M. Gilbride & Julia C. Ford & Kelli Oswald & Rebecca Shoemaker & Yuan Li & Matthew S. Lewis & Awbrey N. Gilliam & Gu, 2017. "Addendum: Immune clearance of highly pathogenic SIV infection," Nature, Nature, vol. 547(7661), pages 123-124, July.
    10. Johannes F. Scheid & Hugo Mouquet & Niklas Feldhahn & Michael S. Seaman & Klara Velinzon & John Pietzsch & Rene G. Ott & Robert M. Anthony & Henry Zebroski & Arlene Hurley & Adhuna Phogat & Bimal Chak, 2009. "Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals," Nature, Nature, vol. 458(7238), pages 636-640, April.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Christoph Kreer & Cosimo Lupo & Meryem S. Ercanoglu & Lutz Gieselmann & Natanael Spisak & Jan Grossbach & Maike Schlotz & Philipp Schommers & Henning Gruell & Leona Dold & Andreas Beyer & Armita Nourm, 2023. "Probabilities of developing HIV-1 bNAb sequence features in uninfected and chronically infected individuals," Nature Communications, Nature, vol. 14(1), pages 1-14, December.
    2. Karunasinee Suphaphiphat & Delphine Desjardins & Valérie Lorin & Nastasia Dimant & Kawthar Bouchemal & Laetitia Bossevot & Maxence Galpin-Lebreau & Nathalie Dereuddre-Bosquet & Hugo Mouquet & Roger Gr, 2023. "Mucosal application of the broadly neutralizing antibody 10-1074 protects macaques from cell-associated SHIV vaginal exposure," Nature Communications, Nature, vol. 14(1), pages 1-13, December.
    3. Nicole A Doria-Rose & Han R Altae-Tran & Ryan S Roark & Stephen D Schmidt & Matthew S Sutton & Mark K Louder & Gwo-Yu Chuang & Robert T Bailer & Valerie Cortez & Rui Kong & Krisha McKee & Sijy O’Dell , 2017. "Mapping Polyclonal HIV-1 Antibody Responses via Next-Generation Neutralization Fingerprinting," PLOS Pathogens, Public Library of Science, vol. 13(1), pages 1-29, January.
    4. Anna Hake & Nico Pfeifer, 2017. "Prediction of HIV-1 sensitivity to broadly neutralizing antibodies shows a trend towards resistance over time," PLOS Computational Biology, Public Library of Science, vol. 13(10), pages 1-23, October.
    5. Jason Gorman & Crystal Sao-Fong Cheung & Zhijian Duan & Li Ou & Maple Wang & Xuejun Chen & Cheng Cheng & Andrea Biju & Yaping Sun & Pengfei Wang & Yongping Yang & Baoshan Zhang & Jeffrey C. Boyington , 2024. "Cleavage-intermediate Lassa virus trimer elicits neutralizing responses, identifies neutralizing nanobodies, and reveals an apex-situated site-of-vulnerability," Nature Communications, Nature, vol. 15(1), pages 1-16, December.
    6. Bailey B. Banach & Sergei Pletnev & Adam S. Olia & Kai Xu & Baoshan Zhang & Reda Rawi & Tatsiana Bylund & Nicole A. Doria-Rose & Thuy Duong Nguyen & Ahmed S. Fahad & Myungjin Lee & Bob C. Lin & Tracy , 2023. "Antibody-directed evolution reveals a mechanism for enhanced neutralization at the HIV-1 fusion peptide site," Nature Communications, Nature, vol. 14(1), pages 1-17, December.
    7. Craig A Magaret & David C Benkeser & Brian D Williamson & Bhavesh R Borate & Lindsay N Carpp & Ivelin S Georgiev & Ian Setliff & Adam S Dingens & Noah Simon & Marco Carone & Christopher Simpkins & Dav, 2019. "Prediction of VRC01 neutralization sensitivity by HIV-1 gp160 sequence features," PLOS Computational Biology, Public Library of Science, vol. 15(4), pages 1-35, April.
    8. Steven Schulz & Sébastien Boyer & Matteo Smerlak & Simona Cocco & Rémi Monasson & Clément Nizak & Olivier Rivoire, 2021. "Parameters and determinants of responses to selection in antibody libraries," PLOS Computational Biology, Public Library of Science, vol. 17(3), pages 1-24, March.
    9. Annemart Koornneef & Kanika Vanshylla & Gijs Hardenberg & Lucy Rutten & Nika M. Strokappe & Jeroen Tolboom & Jessica Vreugdenhil & Karin Feddes-de Boer & Aditya Perkasa & Sven Blokland & Judith A. Bur, 2024. "CoPoP liposomes displaying stabilized clade C HIV-1 Env elicit tier 2 multiclade neutralization in rabbits," Nature Communications, Nature, vol. 15(1), pages 1-16, December.
    10. Lucia Reh & Carsten Magnus & Merle Schanz & Jacqueline Weber & Therese Uhr & Peter Rusert & Alexandra Trkola, 2015. "Capacity of Broadly Neutralizing Antibodies to Inhibit HIV-1 Cell-Cell Transmission Is Strain- and Epitope-Dependent," PLOS Pathogens, Public Library of Science, vol. 11(7), pages 1-34, July.
    11. Kun-Wei Chan & Christina C. Luo & Hong Lu & Xueling Wu & Xiang-Peng Kong, 2021. "A site of vulnerability at V3 crown defined by HIV-1 bNAb M4008_N1," Nature Communications, Nature, vol. 12(1), pages 1-12, December.
    12. Miriam Rosás-Umbert & Jesper D. Gunst & Marie H. Pahus & Rikke Olesen & Mariane Schleimann & Paul W. Denton & Victor Ramos & Adam Ward & Natalie N. Kinloch & Dennis C. Copertino & Tuixent Escribà & An, 2022. "Administration of broadly neutralizing anti-HIV-1 antibodies at ART initiation maintains long-term CD8+ T cell immunity," Nature Communications, Nature, vol. 13(1), pages 1-12, December.
    13. Cyril Planchais & Luis M. Molinos-Albert & Pierre Rosenbaum & Thierry Hieu & Alexia Kanyavuz & Dominique Clermont & Thierry Prazuck & Laurent Lefrou & Jordan D. Dimitrov & Sophie Hüe & Laurent Hocquel, 2023. "HIV-1 treatment timing shapes the human intestinal memory B-cell repertoire to commensal bacteria," Nature Communications, Nature, vol. 14(1), pages 1-17, December.
    14. Durgadevi Parthasarathy & Karunakar Reddy Pothula & Sneha Ratnapriya & Héctor Cervera Benet & Ruth Parsons & Xiao Huang & Salam Sammour & Katarzyna Janowska & Miranda Harris & Joseph Sodroski & Priyam, 2024. "Conformational flexibility of HIV-1 envelope glycoproteins modulates transmitted/founder sensitivity to broadly neutralizing antibodies," Nature Communications, Nature, vol. 15(1), pages 1-15, December.
    15. Wen-Han Yu & Peng Zhao & Monia Draghi & Claudia Arevalo & Christina B Karsten & Todd J Suscovich & Bronwyn Gunn & Hendrik Streeck & Abraham L Brass & Michael Tiemeyer & Michael Seaman & John R Mascola, 2018. "Exploiting glycan topography for computational design of Env glycoprotein antigenicity," PLOS Computational Biology, Public Library of Science, vol. 14(4), pages 1-28, April.
    16. Mathilde Foglierini & Pauline Nortier & Rachel Schelling & Rahel R. Winiger & Philippe Jacquet & Sijy O’Dell & Davide Demurtas & Maxmillian Mpina & Omar Lweno & Yannick D. Muller & Constantinos Petrov, 2024. "RAIN: machine learning-based identification for HIV-1 bNAbs," Nature Communications, Nature, vol. 15(1), pages 1-16, December.
    17. Svenja Weiss & Vincenza Itri & Ruimin Pan & Xunqing Jiang & Christina C. Luo & Lynn Morris & Delphine C. Malherbe & Philip Barnette & Jeff Alexander & Xiang-Peng Kong & Nancy L. Haigwood & Ann J. Hess, 2022. "Differential V2-directed antibody responses in non-human primates infected with SHIVs or immunized with diverse HIV vaccines," Nature Communications, Nature, vol. 13(1), pages 1-15, December.
    18. Jocelyn T. Kim & Tian-Hao Zhang & Camille Carmona & Bryanna Lee & Christopher S. Seet & Matthew Kostelny & Nisarg Shah & Hongying Chen & Kylie Farrell & Mohamed S. A. Soliman & Melanie Dimapasoc & Mic, 2022. "Latency reversal plus natural killer cells diminish HIV reservoir in vivo," Nature Communications, Nature, vol. 13(1), pages 1-14, December.
    19. Luis M. Molinos-Albert & Valérie Lorin & Valérie Monceaux & Sylvie Orr & Asma Essat & Jérémy Dufloo & Olivier Schwartz & Christine Rouzioux & Laurence Meyer & Laurent Hocqueloux & Asier Sáez-Cirión & , 2022. "Transient viral exposure drives functionally-coordinated humoral immune responses in HIV-1 post-treatment controllers," Nature Communications, Nature, vol. 13(1), pages 1-17, December.
    20. Hongjun Bai & Eric Lewitus & Yifan Li & Paul V. Thomas & Michelle Zemil & Mélanie Merbah & Caroline E. Peterson & Thujitha Thuraisamy & Phyllis A. Rees & Agnes Hajduczki & Vincent Dussupt & Bonnie Sli, 2024. "Contemporary HIV-1 consensus Env with AI-assisted redesigned hypervariable loops promote antibody binding," Nature Communications, Nature, vol. 15(1), pages 1-16, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-51848-y. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.